Poor glycaemic control has been implicated in the development of chronic metabolic diseases like obesity, type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) and decreased cognitive performance. In addition, with the recent worldwide spread of SARS-CoV-2, obesity and impaired metabolic health also emerged as important determinants of severe coronavirus disease 2019 (COVID-19).Watch the presentations to find out more on glycaemic control, metabolic and mental health. Finally, watch the panel discussion to get insights on the impact on the food industry of the ongoing research on glycaemic control & health.

Glycaemic control and (cardio) metabolic health risks

Prof. Ellen Blaak (Maastricht University)

Glycaemic control and cognitive function

Prof. Louise Dye (University of Leeds)

Glycaemic control, impaired metabolic health and COVID-19

Prof. Norbert Stefan (University Hospital Tübingen)

Impact of Research on Glycemic Control

Panel discussion